文献速递泌尿生殖腹部MR

应用扩散及临床病理特征预测非肌层浸润性膀胱尿路上皮癌复发风险

Recurrence risk prediction for non-muscle-invasive bladder urothelial carcinoma using diffusion and clinicopathology features.
PubMed 文献 · Abdom Radiol (NY) · 2025-05-28

回顾性单中心研究纳入135例组织学确诊的非肌层浸润性膀胱尿路上皮癌,分析ADC值、VI-RADS评分及临床病理变量与无复发生存的关系。多因素分析显示ADC值、血红蛋白水平和病理分级为独立预测因子,联合模型C指数0.724。基于ADC≤1343.22×10⁻⁶ mm²/s、血红蛋白<113.2 g/L和病理分级的风险分层区分能力优于EAU标准(C指数0.667 vs 0.605)。

要点

  • ADC值、血红蛋白水平和病理分级是非肌层浸润性膀胱尿路上皮癌复发的独立预测因子,VI-RADS评分无独立预后价值。
  • 基于ADC≤1343.22×10⁻⁶ mm²/s、血红蛋白<113.2 g/L和病理分级的风险分层C指数0.667,优于EAU标准的0.605。
  • 联合ADC值、血红蛋白和病理分级的模型预测复发C指数为0.724(95%CI 0.655-0.794)。

核心结论

  • 整合定量ADC指标、血红蛋白水平和病理分级的风险分层框架在预测非肌层浸润性膀胱尿路上皮癌复发方面优于传统EAU分层,提供了可用于个体化风险分层的临床阈值。

研究设计与样本

  • 回顾性单中心研究,纳入2015年1月至2023年3月经组织学确诊的非肌层浸润性膀胱尿路上皮癌135例,分析ADC值、VI-RADS评分及临床病理变量,以无复发生存为主要终点,采用单因素和多因素Cox比例风险回归筛选预后因素,并以C指数与EAU风险分类进行比较验证。

诊断标准与关键数值

  • 多因素分析独立预测因子:ADC值HR=0.104(95%CI 0.025-0.436),血红蛋白水平HR=0.463(95%CI 0.223-0.960),病理分级HR=2.079(95%CI 1.098-3.936)。联合模型C指数=0.724(95%CI 0.655-0.794)。风险分层阈值:ADC≤1343.22×10⁻⁶ mm²/s、血红蛋白<113.2 g/L、病理分级。风险分层C指数0.667 vs EAU标准0.605。

临床应用与阅片要点

  • 阅片时可测量ADC值并以≤1343.22×10⁻⁶ mm²/s作为风险分层阈值之一,结合血红蛋白<113.2 g/L和病理分级进行复发风险分层,VI-RADS评分在本研究中未见独立预后价值。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the prognostic value of apparent diffusion coefficient (ADC) metrics, MRI characteristics, and clinicopathological parameters in predicting non-muscle-invasive bladder urothelial carcinoma (UCB) recurrence, and to develop a novel multiparametric risk stratification framework.

METHODS: This retrospective single-center study (n = 135) with histologically confirmed non-muscle-invasive UCB diagnosed between January 2015 and March 2023. ADC values, vesical imaging reporting and data system (VI-RADS) scores, and clinicopathological variables were analyzed with recurrence-free survival (RFS) as the primary endpoint. Prognostic determinants were identified using univariate and multivariate Cox proportional hazard regression models. An advanced risk stratification system was developed using independent predictors and validated against the European Association of Urology (EAU) risk classification using concordance index (C-index).

RESULTS: Multivariate analysis identified three independent predictors: ADC values (HR = 0.104, 95% confidence interval (CI) 0.025-0.436), hemoglobin levels (HR = 0.463, 95% CI 0.223-0.960), and pathological grade (HR = 2.079, 95% CI 1.098-3.936). The combined model incorporating these parameters demonstrated moderate predictive accuracy (C-index = 0.724, 95% CI 0.655-0.794). Notably, VI-RADS scores showed no independent prognostic value. Risk stratification based on ADC (≤ 1343.22 × 10⁻⁶ mm²/s), hemoglobin (< 113.2 g/L), and pathological grade demonstrated superior discriminative capacity compared to EAU criteria (C-index: 0.667 vs. 0.605).

CONCLUSION: A multidimensional prognostic framework integrating quantitative ADC metrics, hemoglobin levels, and pathological grading significantly outperforms conventional EAU stratification in predicting non-muscle-invasive UCB recurrence, providing clinically actionable thresholds for personalized risk stratification and UCB management.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zhang X, Guo J, Wang L, et al. Recurrence risk prediction for non-muscle-invasive bladder urothelial carcinoma using diffusion and clinicopathology features. Abdom Radiol (NY). 2025. PMID: 40434425. doi:10.1007/s00261-025-05023-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。